Tekla Capital Management LLC Affimed N.V. Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in Affimed N.V. stock. As of the latest transaction made, Tekla Capital Management LLC holds 586,038 shares of AFMD stock, worth $697,385. This represents 0.01% of its overall portfolio holdings.
Number of Shares
586,038
Previous 586,038
-0.0%
Holding current value
$697,385
Previous $439,000
20.05%
% of portfolio
0.01%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding AFMD
# of Institutions
3Shares Held
1.09MCall Options Held
0Put Options Held
0About Affimed N.V.
- Ticker AFMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,339,008
- Market Cap $178M
- Description
- Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...